HAEMONETICS CORP

HAE · XNYS

CIK 313143fmd_0BKM5ZZM8Y46Z1YQXRSAQPZH7TManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Mar 30, 2008 to Sep 26, 2026, 71 periods

Income Statement · Annual · Millions · USD
Line item	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Total revenues	886	904	968	988	870	993	1,169	1,309	1,361	1,334
Cost of revenue	508	492	550	504	473	488	554	618	612	546
Gross profit	378	412	418	485	398	506	615	692	749	788
Realized investment gains (losses)	–	–	–	–	–	–	0	0	0	–
Research and development	38	39	36	31	33	47	50	54	63	60
Selling, general and administrative	302	317	273	282	275	340	377	430	437	442
Total operating expenses	398	356	334	381	308	425	459	527	527	631
Operating income	(19)	56	84	103	90	81	156	165	222	157
Interest expense	–	8	13	14	9	6	13	20	36	19
Interest and investment income	–	–	–	–	–	–	–	–	–	–
Other non-operating income (expense)	(8)	(5)	(10)	(16)	(17)	(17)	(15)	(13)	(10)	(29)
Income before taxes	(27)	60	74	87	73	64	141	152	212	128
Income tax expense	(1)	14	19	11	(7)	20	26	34	44	31
Net income from continuing operations	(26)	46	55	77	79	43	115	118	168	97
Net income	(26)	46	55	77	79	43	115	118	168	97